Liver regeneration is not altered in patients with nonalcoholic steatohepatitis (NASH) when compared to chronic hepatitis C infection with similar grade of inflammation

Digestive Diseases and Sciences

Volumn 47, Issue 9, 2002, Pages 1926-1931

  Hussein, Osamah ^a   Szvalb, Sergio ^a   Van den Akker Berman, L M ^a   Assy, Nimer ^a  

^a Rebecca Sieff Government Hospital   (Israel)

Author keywords

Fatty liver; Hepatic steatosis; Hepatitis C; Ki 67 immunostaining; Liver regeneration; NASH

Indexed keywords

KI 67 ANTIGEN;

ADULT; ARTICLE; FATTY LIVER; FEMALE; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LIVER FAILURE; LIVER FIBROSIS; LIVER REGENERATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; FATTY LIVER; FEMALE; HEPATECTOMY; HEPATITIS C, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LIVER; LIVER REGENERATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0036715546     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019679603042     Document Type: Article

References (35)

1. Liver regeneration
2. Proliferative activity of hepatocytes in chronic viral hepatitis as revealed by immunohistochemistry for proliferating cell nuclear antigen
3. DNA polymerases and Ki-67 nuclear antigen are induced in correlation with the resected mass of rat liver up to 90%
4. Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation
5. Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis
6. Expression of cyclin-dependent kinase inhibitor p21 in human liver
7. Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going?
8. Non-alcoholic steato-hepatitis: Association with obesity and insulin resistance, and influence of weight loss
9. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
10. Liver histology in a normal population-examinations of 503 consecutive fatal traffic casualties
11. Hepatic steatosis: Innocent bystander or guilty party?
12. Hepatic steatosis as a potential risk factor for major hepatic resection
13. Primary nonfunction of hepatic allografts with pre-existing fatty infiltration
14. Liver resection for colorectal metastases
15. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation
16. Posner: Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation
17. Failure of regeneration of the steatotic rat liver: Disruption at two different levels in the regeneration pathway
18. Liver injury following normothermic ischemia in steatotic rat liver
19. Does steatohepatitis impair liver regeneration? A study in a dietary model of non-alcoholic steatohepatitis in rats
20. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: The role of etiology, disease activity, iron and lipid peroxidation
21. Hepatic regeneration in humans with various liver disease as assessed by Ki-67 staining of formalin-fixed paraffin-embedded liver tissue
22. Chronic hepatitis. An update on terminology and reporting
23. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
24. Comparison between non-alcoholic steatohepatitis and alcoholic hepatitis
25. Chronic ethanol administration to rats decreases receptor -operated mobilization of intracellular calcium in cultured hepatocytes and inhibits inositol 1,4,5-triphosphate production: Relevance to impaired liver regeneration
26. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type 1 tumor necrosis factor receptor
27. Liver failure and defective hepatocyte regeneration in interleukin-6 deficient mice
28. Obesity increases sensitivity to endotoxin liver injury: Implication for the pathogenesis of steatohepatitis
29. Liver regeneration: Methods for monitoring and their applications
30. Studies of hepatic warm ischemia in the obese Zucker rat
31. Impaired mitochondrial function in microvesicular steatosis
32. Age related increases in plasma phosphatidylcholine hydroperoxide concentration in control subjects and in patients with hyperlipidemia
33. Radicals and oxidative stress in diabetes
34. S-phase cells in diseases human liver determined by an in-vitro BrdU-antiBrdU method
35. Ki-67 expression during rat liver regeneration after partial hepatectomy